DiscoverTaking Control Of Your Diabetes® - The Podcast!GLP 1s - One Class of Drugs with Many Different Names
GLP 1s - One Class of Drugs with Many Different Names

GLP 1s - One Class of Drugs with Many Different Names

Update: 2025-04-14
Share

Description

In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman go head-to-head in a friendly face-off between two of the most talked-about medications in diabetes and weight management: Ozempic and Mounjaro. Both are part of the powerful GLP-1 class, but which one might be better for you? From A1C reduction and weight loss to heart and kidney protection, ease of use, side effects, and insurance coverage—Drs. E & P walk you through a category-by-category comparison. They bring the clinical data and their own real-world patient experience to help you understand the key differences (and similarities) between these leading therapies. Whether you're managing type 2 diabetes, living with type 1, or exploring options for weight loss, this episode is designed to help you make an informed decision with your healthcare provider.

Key Topics:

  • How These Medications Work: Learn the difference between GLP-1 and dual agonist therapies
  • A1C Reduction: See which drug leads to greater blood sugar improvements based on head-to-head clinical trials.
  • Weight Loss: Discover how much weight patients lose on each medication—and why Mounjaro often shows stronger results.
  • Heart Health: Understand which medication has FDA approval for cardiovascular protection and what’s still under investigation.
  • Kidney Protection: Explore the latest studies showing Ozempic’s ability to slow kidney disease progression.
  • Side Effects: Get practical tips on managing common GI side effects and why titration matters.
  • Ease of Use: Compare how the pens work, dosing flexibility, and what may be easier for patients day to day.
  • Sleep Apnea: Find out how Mounjaro earned a new indication for reducing sleep apnea severity—especially through weight loss.
  • Access for Type 1s: Learn why these meds aren’t yet approved for T1D and how some patients are still getting them.
  • Emerging Indications: Hear about new uses for these meds, including fatty liver, osteoarthritis, and even alcohol reduction.
  • How to Choose: Get expert guidance on which medication may be right for you based on your goals and health needs.

Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org

**Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**

Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook  |  Instagram  |  YouTube



★ Support this podcast ★
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

GLP 1s - One Class of Drugs with Many Different Names

GLP 1s - One Class of Drugs with Many Different Names

Taking Control Of Your Diabetes®